Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Clinical Efficacy of Erythroid Stimulating Agent (ESA) and Luspatercept (LUSPA) in Vexas Syndrome with or without Myelodysplastic Syndrome (MDS) : A Multicenter Retrospective Study By the Frenvex Group

Mael Heiblig, Vincent Jachiet, Jerome Hadjadj, Lin Pierre Zhao, Thibault Comont, Hervé Lobbes, Valentin Lacombe, Anne Blandine Boutin, Joris Galland, Yesim Dargaud, Benjamin Terrier, Sophie Georgin-Lavialle, Pierre Fenaux, Arsene Mekinian

Blood (2024) 144 (Supplement 1): 2674.

https://doi.org/10.1182/blood-2024-210879

Published: 2024

Journal Articles

Serious Infections in Patients with Vexas Syndrome: A Study from the French Vexas Group

Blood (2023) 142 (Supplement 1): 5599.

https://doi.org/10.1182/blood-2023-178254

Published: 2023

Journal Articles

Genotype-Phenotype Mapping Via Single-Cell Multi-Omics Identifies Therapeutic Vulnerabilities in Vexas Syndrome

Saravanan Ganesan, Rebecca Murray, Jesus Sotelo, Theo Botella, Elliot Eton, Nada Chraiki, Carolyne Croizier, Franco Izzo, Catherine Potenski, Benjamin Terrier, Mael Heiblig, Pierre Sujobert, Olivier Kosmider, David B Beck, Dan A. Landau

Blood (2023) 142 (Supplement 1): 813.

https://doi.org/10.1182/blood-2023-184313

Published: 2023

Journal Articles

Azacitidine for Patients with Vexas Syndrome: Data from the French Vexas Registry

Thibault Comont, Olivier Kosmider, Mael Heiblig, Benjamin Terrier, Didier Bouscary, Guillaume Le Guenno, Roderau Outh, Maxime Samson, Achille Aouba, Estibaliz Lazarro, Odile Rauzy, Lucie Rigolot, Pierre Peterlin, Alexandre Maria, Edouard Flammarion, Alice Garnier, Benoit De Renzis, Shanti Natarajan, Benjamin Carpentier, Marielle Roux-Sauvat, Jose Torregrosa, Fabienne Closs-Prophette, Julien Rossignol, Nicolas Schleinitz, Celine Dieval, Jonahan Broner, Marie-Pierre Gourin, Gaetan Sauvetre, Benoit Faucher, Julien Vinit, Sylvie Grosleron, Alexis Mathian, Louis Terriou, Cyrille Coustal, Philippe Guilpain, Paola Marianetti-Guingel, Holy Bezanahary, Norbert Vey, Bilal Mohty, Thomas Moulinet, Vincent Grobost, Sophie Dimicoli, Benoit Suzon, Antoinette Perlat, Pierre Hirsh, Lise Larcher, Lin Pierre Zhao, Sophie Georgin-Lavialle, Arsene Mekinian, Pierre Fenaux, Vincent Jachiet, French VEXAS study group, Minhemon French Network of immune disorders associated with hemopathies, GFM Groupe Francophone des Myélodysplasies

Blood (2023) 142 (Supplement 1): 4604.

https://doi.org/10.1182/blood-2023-178125

Published: 2023

Journal Articles

Novel Disease-Causing Mutations in UBA1 Reveal Disease Mechanisms in Bone Marrow Failure and Inflammation

Jason C Collins, Nicholas Balanda, Samuel J Magaziner, Maya English, Daniela Ospina Cardona, Mrinal M. Patnaik, Benjamin Terrier, Olivier Kosmider, Achim Werner, David B. Beck

Blood (2022) 140 (Supplement 1): 2914–2915.

https://doi.org/10.1182/blood-2022-168031

Published: 2022

Journal Articles

Clonal hematopoiesis is not significantly associated with COVID-19 disease severity

Blood (2022) 140 (14): 1650–1655.

https://doi.org/10.1182/blood.2022015721

Published: 2022

Includes: Supplemental data

Journal Articles

Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma

Blood (2022) 139 (6): 942–946.

https://doi.org/10.1182/blood.2021013714

Published: 2022

Includes: Supplemental data

Journal Articles

Azacitidine (AZA) for Patients with Vexas and Myelodysplastic Syndrome (MDS): Data from the French Vexas Registry

Thibault Comont, Maël Heiblig, Jeremie Dion, Etienne Riviere, Louis Terriou, Julien Rossignol, Virginie Rieu, Guillaume Le Guenno, Alexis Mathian, Achille Aouba, Julien Vinit, Benjamin Terrier, Olivier Kosmider, Sophie Georgin-Lavialle, Pierre Fenaux, Arsene Mekinian

Blood (2021) 138 (Supplement 1): 3689.

https://doi.org/10.1182/blood-2021-152363

Published: 2021

Journal Articles

Can Rituximab be Useful for Treating SLE-Associated Immune Cytopenias ? Results from a Retrospective Multicentre Study on 62 Patients

Alexandra Serris, MD, Zahir Amoura, MD MSc, Benjamin Terrier, MD PhD, Eric Hachulla, MD PhD, Nathalie Costedoat-Chalumeau, MD PhD, Thomas Papo, MD, Olivier Lambotte, MD PhD, David Saadoun, MD PhD, Miguel Hie, MD, Philippe Blanche, Corinne Haioun, MD, Bertrand Lioger, Bertrand Godeau, MD PhD, Marc Michel, MD

Blood (2016) 128 (22): 870.

https://doi.org/10.1182/blood.V128.22.870.870

Published: 2016

Journal Articles

Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey

Blood (2012) 119 (25): 5996–6004.

https://doi.org/10.1182/blood-2011-12-396028

Published: 2012

Includes: Supplemental data

Journal Articles

Interleukin-25: a cytokine linking eosinophils and adaptive immunity in Churg-Strauss syndrome

Benjamin Terrier, Ivan Bièche, Thierry Maisonobe, Ingrid Laurendeau, Michèlle Rosenzwajg, Jean-Emmanuel Kahn, Marie-Claude Diemert, Lucile Musset, Michel Vidaud, Damien Sène, Nathalie Costedoat-Chalumeau, Du Le Thi-Huong, Zahir Amoura, David Klatzmann, Patrice Cacoub, David Saadoun

Blood (2010) 116 (22): 4523–4531.

https://doi.org/10.1182/blood-2010-02-267542

Published: 2010

Journal Articles

High Frequency of Marginal Zone Lymphomas Among Patients Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus - ANRS CO16 LYMPHOVIR Cohort Study

Benjamin Terrier, Dominique Costagliola, Houria Chavez, Danielle Canioni, MD, Régis Costello, Lilia Escaut, Bertrand Joly, Lorraine Le Tranchant, Pascale Morineau-Le Houssine, Anne Simon, Yassine Taoufik, Sophie Prevot, Patrice Cacoub, Martine Raphael, MD, PhD, Caroline Besson

Blood (2010) 116 (21): 4156.

https://doi.org/10.1182/blood.V116.21.4156.4156

Published: 2010

Journal Articles

Rituximab plus Peg-interferon-α/ribavirin compared with Peg-interferon-α/ribavirin in hepatitis C–related mixed cryoglobulinemia

David Saadoun, Mathieu Resche Rigon, Damien Sene, Benjamin Terrier, Alexandre Karras, Laurent Perard, Yoland Schoindre, Brigitte Coppéré, François Blanc, Lucile Musset, Jean-Charles Piette, Michele Rosenzwajg, Patrice Cacoub

Blood (2010) 116 (3): 326–334.

https://doi.org/10.1182/blood-2009-10-248518

Published: 2010

NARROW

Clinical Efficacy of Erythroid Stimulating Agent (ESA) and Luspatercept (LUSPA) in Vexas Syndrome with or without Myelodysplastic Syndrome (MDS) : A Multicenter Retrospective Study By the Frenvex Group

Serious Infections in Patients with Vexas Syndrome: A Study from the French Vexas Group

Genotype-Phenotype Mapping Via Single-Cell Multi-Omics Identifies Therapeutic Vulnerabilities in Vexas Syndrome

Azacitidine for Patients with Vexas Syndrome: Data from the French Vexas Registry

Novel Disease-Causing Mutations in UBA1 Reveal Disease Mechanisms in Bone Marrow Failure and Inflammation

Clonal hematopoiesis is not significantly associated with COVID-19 disease severity

Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma

Azacitidine (AZA) for Patients with Vexas and Myelodysplastic Syndrome (MDS): Data from the French Vexas Registry

Can Rituximab be Useful for Treating SLE-Associated Immune Cytopenias ? Results from a Retrospective Multicentre Study on 62 Patients

Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey

Interleukin-25: a cytokine linking eosinophils and adaptive immunity in Churg-Strauss syndrome

High Frequency of Marginal Zone Lymphomas Among Patients Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus - ANRS CO16 LYMPHOVIR Cohort Study

Rituximab plus Peg-interferon-α/ribavirin compared with Peg-interferon-α/ribavirin in hepatitis C–related mixed cryoglobulinemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only